Background. Human immunodeficiency virus type 1 (HIV-1) may utilize the CXCR4 coreceptor (X4 virus), the CCR5 coreceptor (R5 virus), or both (dual/mixed [DM] virus). We analyzed HIV-1 coreceptor tropism in Ugandan infants enrolled in the HIVNET (HIV Network for Prevention Trials) 012 trial. Methods. Plasma or serum was analyzed using a commercial coreceptor tropism assay. HIV env subtype was determined by phylogenetic methods. Results. Tropism results were obtained for 57 samples from infants collected 6–14 weeks after birth. Fifty-two infants had only R5 virus, and 5 had either X4 or DM virus. The mothers of those 5 infants also had X4 or DM virus. In infants, subtype D infection was associated with high-level infectivity in CCR5-bearing c...
This study was carried out to characterize HIV-1 reverse transcriptase (RT) mutations in vertically ...
AbstractIt is widely documented that a complete switch from the predominant CCR5 (R5) to CXCR4 (X4) ...
With limited and low-genetic barrier drugs used for the prevention of mother-to-child transmission (...
HIV-infected infants may have CXCR4-using (X4-tropic) HIV, CCR5-using (R5-tropic) HIV, or a mixture ...
In human immunodeficiency virus type 1 (HIV-1) subtype B, CXCR4 coreceptor use ranges from 20 % in e...
The aim of this study was to determine the coreceptor tropism by performing genotypic HIV-1 tropism ...
In a series of 97 infants born to mothers who were seropositive for human immunodeficiency virus typ...
The level of viral diversity in an HIV-infected individual can change during the course of HIV infec...
It remains unknown whether the C-C motif chemokine receptor type 5 (CCR5) coreceptor is still the pr...
BACKGROUND: HIV-1 R5 viruses are characterized by a large phenotypic variation, that is reflected by...
Background. Human immunodeficiency virus type 1 (HIV-1) coreceptor tropism, the ability of the virus...
Change of HIV-1 coreceptor use has been connected to progression of disease in children infected wit...
BACKGROUND: HIV-1 R5 viruses are characterized by a large phenotypic variation, that is reflected by...
Coreceptor use was determined for human immunodeficiency virus type 1 (HIV-1) isolates of various su...
Coreceptor usage of primary HIV-1 isolates was analysed in relation to their biological phenotype an...
This study was carried out to characterize HIV-1 reverse transcriptase (RT) mutations in vertically ...
AbstractIt is widely documented that a complete switch from the predominant CCR5 (R5) to CXCR4 (X4) ...
With limited and low-genetic barrier drugs used for the prevention of mother-to-child transmission (...
HIV-infected infants may have CXCR4-using (X4-tropic) HIV, CCR5-using (R5-tropic) HIV, or a mixture ...
In human immunodeficiency virus type 1 (HIV-1) subtype B, CXCR4 coreceptor use ranges from 20 % in e...
The aim of this study was to determine the coreceptor tropism by performing genotypic HIV-1 tropism ...
In a series of 97 infants born to mothers who were seropositive for human immunodeficiency virus typ...
The level of viral diversity in an HIV-infected individual can change during the course of HIV infec...
It remains unknown whether the C-C motif chemokine receptor type 5 (CCR5) coreceptor is still the pr...
BACKGROUND: HIV-1 R5 viruses are characterized by a large phenotypic variation, that is reflected by...
Background. Human immunodeficiency virus type 1 (HIV-1) coreceptor tropism, the ability of the virus...
Change of HIV-1 coreceptor use has been connected to progression of disease in children infected wit...
BACKGROUND: HIV-1 R5 viruses are characterized by a large phenotypic variation, that is reflected by...
Coreceptor use was determined for human immunodeficiency virus type 1 (HIV-1) isolates of various su...
Coreceptor usage of primary HIV-1 isolates was analysed in relation to their biological phenotype an...
This study was carried out to characterize HIV-1 reverse transcriptase (RT) mutations in vertically ...
AbstractIt is widely documented that a complete switch from the predominant CCR5 (R5) to CXCR4 (X4) ...
With limited and low-genetic barrier drugs used for the prevention of mother-to-child transmission (...